This likely stems from the removal of the tumor-driven angiogenic microenvironment, where tumors secrete factors like VEGF that stimulate VASH1 and iNOS expression in WBCs, enhancing NO production to support vascularization [2–4]. The gene discussed is NOS2; the disease is neoplasm.